Watchlist Price Alert

RVL Pharmaceuticals (OSMT)

NASDAQ: OSMT · Real-Time Price · USD

1.11

-0.02 (-1.77%)

At close: Jan 19, 2022, 5:00 AM

RVL Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Net Income	-51.69M	-64.92M	-79.59M	-270.9M	-109.68M	-45.15M	-41.82M
Depreciation & Amortization	375K	8.18M	21.03M	57.02M	81.57M	46.45M	23.59M
Stock-Based Compensation	4.07M	7.59M	4.92M	4.93M	1.97M	n/a	n/a
Other Working Capital	6.6M	-17.03M	-21M	-15.15M	9.95M	737.37K	-31.97M
Other Non-Cash Items	5.14M	2.08M	74.24M	285.09M	105.07M	91.55M	32.93M
Deferred Income Tax	-90K	-194K	-1.16M	-26.79M	-15.51M	-44.49M	-13.16M
Change in Working Capital	4.39M	-7.46M	-1.86M	-15.78M	-25.86M	9.49M	-46.33M
Operating Cash Flow	-37.81M	-54.73M	17.59M	33.57M	37.56M	57.84M	-44.79M
Capital Expenditures	-752K	-1.78M	-3.13M	-4.04M	-4.14M	-6.9M	-15.93M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a	-321M
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	878K	118.23M	50K	17K	10K	-12.5M	-118.53M
Investing Cash Flow	126K	116.45M	-3.08M	-4.02M	-4.13M	-19.4M	-453.46M
Debt Repayment	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	-8.1M	-2.79M	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	-23.31M
Other Financial Acitivies	41.78M	-135.33M	3.68M	-4.69M	3.6M	-23.31M	443.82M
Financial Cash Flow	41.78M	-135.33M	3.68M	-4.69M	3.6M	-23.31M	420.52M
Net Cash Flow	4.1M	-73.61M	18.19M	25.03M	36.09M	15.18M	-78.05M
Free Cash Flow	-38.56M	-56.51M	14.46M	29.53M	33.41M	50.94M	-60.72M